John George Petrovich - Net Worth and Insider Trading
John George Petrovich Net Worth
The estimated net worth of John George Petrovich is at least $33,276 dollars as of 2024-11-13. John George Petrovich is the Subsidiary CEO of Arrowhead Pharmaceuticals Inc and owns about 1,547 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $33,276. Details can be seen in John George Petrovich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John George Petrovich has not made any transactions after 2007-01-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John George Petrovich
John George Petrovich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John George Petrovich owns 2 companies in total, including Axonics Inc (AXNX) , and Arrowhead Pharmaceuticals Inc (ARWR) .
Click here to see the complete history of John George Petrovich’s form 4 insider trades.
Insider Ownership Summary of John George Petrovich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXNX | Axonics Inc | 2018-10-30 | director & 10 percent owner |
| ARWR | Arrowhead Pharmaceuticals Inc | 2007-01-01 | Subsidiary CEO |
John George Petrovich Latest Holdings Summary
John George Petrovich currently owns a total of 1 stock. John George Petrovich owns 1,547 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 1, 2007, with a value of $33,276.
Latest Holdings of John George Petrovich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2007-01-01 | 1,547 | 21.51 | 33,276 |
Holding Weightings of John George Petrovich
John George Petrovich Form 4 Trading Tracker
According to the SEC Form 4 filings, John George Petrovich has made a total of 0 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 0 shares on January 1, 2007, which brought John George Petrovich around $0.
Insider Trading History of John George Petrovich
- 1
John George Petrovich Trading Performance
John George Petrovich Ownership Network
Ownership Network List of John George Petrovich
Ownership Network Relation of John George Petrovich
John George Petrovich Owned Company Details
What does Axonics Inc do?
Who are the key executives at Axonics Inc?
John George Petrovich is the director & 10 percent owner of Axonics Inc. Other key executives at Axonics Inc include Chief Financial Officer Kari Leigh Keese , Chief Medical Officer Karen Noblett , and director & Chief Executive Officer Raymond W Cohen .
Axonics Inc (AXNX) Insider Trades Summary
Over the past 18 months, John George Petrovich made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 15,674 shares made by Danny L. Dearen .
In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 141,355 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 141,355 shares.
Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axonics Inc Insider Transactions
John George Petrovich Mailing Address
Above is the net worth, insider trading, and ownership report for John George Petrovich. You might contact John George Petrovich via mailing address: Calando Pharmaceuticals Inc., 2585 Nina Street, Pasadena Ca 91107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
